Sovereign Nations cover image

A Politicized FDA | Public Occurrences, Ep. 13

Sovereign Nations

00:00

Vaccines Need to Be Effective Until New Clinical Trials Define It

Waning efficiency has the potential to be far more than a minor inconvenience. It can dramatically change the risk benefit calculus. Until new clinical trials demonstrate that boosters increase efficacy above 50 % without increasing serious adverse events, it is unclear whether the two dose series would even meet the f d a's approval standard at six or nine months.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app